A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis

计划入组 116 人 · 首次发布于 2017 年 9 月 7 日

PETHEMA-BLIN-01/PET069014 (BLIN-01)

计划入组 11 人 · 首次发布于 2018 年 5 月 14 日

Pharmacodynamics of NPC-01/IKH-01; Effect of NPC-01/IKH-01 on Sexual Hormone Concentrations in Healthy Female Volunteers

计划入组 14 人 · 首次发布于 2010 年 12 月 3 日

YRA-1909

ThV-01

AS-01

01 Communique Laboratory Inc

Canada

Miragen Therapeutics, Inc.

Renovaro

United States

Y.ora Vision Launches with Novel MIGS Device for Glaucoma Treatment Following SERI-Eyexora Licensing Deal

Kiromic BioPharma's Deltacel Shows Promise in NSCLC Trial, Moves to Dose Expansion

Breakthrough Humanized Antibody VX-01 Shows Promise Against Deadly Mucormycosis